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Abstract 
Extended-spectrum beta-lactamases (ESBLs) are enzymes that are capable of degrading 
frequently used beta-lactam antibiotics such as penicillin and cephalosporins. Organisms that 
produce these enzymes are often multi-drug resistant. ESBLs are commonly produced by the 
Enterobacteriaceae group of gram negative bacteria that are naturally occurring gut microbiota. 
Currently, ESBLs pose a significant health threat due to their ability to cause a multitude of 
difficult to treat infections, and are one of the leading causes of death world-wide. The bla genes 
that code for ESBL can be passed via horizontal transmission. As of yet, there is no data on 
prevalence of ESBL-producing Enterobacteriaceae in North Georgia water sources. Flat creek is 
located in North Georgia and runs directly into Lake Lanier, which is a main source of drinking 
water for the Atlanta area as well as a popular spot for water recreation. We obtained efferent 
and afferent water samples from Flat Creek Water Reclamation Center in Hall County Georgia. 
These water samples were filtered, grown in an enrichment media and plated on selective media 
that yielded the isolation of ESBL-producing Enterobacteriaceae. We found ESBL producing 
enterobacteria in all the samples we tested. Further identification methods revealed the presence 
of ESBL producing Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, 
Citrobacter freundii and Escherichia coli. Following identification, disk diffusion method was 
used to test susceptibility of the isolates to several commonly used antibiotics. This testing 
revealed that all isolates were multi-drug resistant. Lastly, DNA was extracted from the isolates 
to confirm the presence of bla genes that encode for ESBLs by agarose gel electrophoresis. 
Forty-two percent of the isolates were confirmed to be carrying one or more of the bla genes. 
Introduction 
Antibiotics are essential in modern medicine for fighting infectious diseases, and are vital to the 
survival of vulnerable patient populations with weakened immune systems. The overprescribing 
and misuse of antibiotics across human and animal populations has led to selection of antibiotic 
resistant bacteria (ARB). The consistent antibiotic pressure placed on bacteria facilitates ARB 
“superbugs” to thrive and flourish. (Chen et al., 2010). When common antibiotics become 
ineffective, increasingly toxic antibiotics are often the only option. Patients who acquire resistant 
infections face much higher morbidity and mortality rates. ESBLs are one such mechanism for 
bacteria to confer resistance. Extended-spectrum beta-lactamases (ESBLs) are enzymes that 
hydrolyze extended-spectrum cephalosporins with an oxyimino side chain, cleaving the beta-
lactam ring, inactivating the antibiotic. The mechanism by which this occurs is rearrangement of 
the amino acid sequences of the active sites. (Patterson., 2003) 
Since first identified in 1983, ESBLs have become increasingly prevalent because ESBL 
enzymes can be plasmid mediated, thus their resistant genes are easily transferred between 
bacterial strains via horizontal and vertical gene transmission. Resistances to β-lactams mediated 
by extended-spectrum β-lactamases (ESBL) are especially relevant among Enterobacteriaceae 
(Ojer-Usoz, 2014). Antibiotics are essential in modern medicine for fighting infectious diseases, 
and are vital to the survival of vulnerable patient populations with weakened immune systems. 
The overprescribing and misuse of antibiotics across human and animal populations has caused 
the selection of antibiotic resistant bacteria (ARB). This consistent antibiotic pressure placed on 
bacteria facilitates ARB “superbugs” to thrive and flourish. (Chen et al., 2010). When common 
antibiotics become ineffective, increasingly toxic antibiotics are often the only option. Patients 
who acquire resistant infections face much higher morbidity and mortality rates. 
Aquatic environments have a significant role in transmitting ARB to human populations. 
Bacteria originating from numerous sources such as hospitals and livestock are washed into 
wastewater, via watershed and disposal methods, where they amalgamate and then the bacteria 
have the ability transfer resistance genes via horizontal transmission, through plasmid mediated 
genes. Consequently, water establishes an ideal path for the dissemination of resistant bacterial 
genes among human and animal populations, as well as naturally occurring bacterial ecosystems 
(Ojer-Usoz, 2014). Hospital waste compounds the problem of spreading resistance. Waste from 
patients colonized with ARB along with large amounts of antimicrobials are released into 
wastewater and represent a continuous selective pressure upon the ARB. Antimicrobial selective 
pressure favors horizontal transfer of resistance genes among and between different species of 
bacteria (Hocquet, 2016). 
ESBLs are derivatives of the plasmid-mediated enzyme families of TEM (temoniera), SHV 
(sulfhydral variable), and OXA (oxacillin) (Patterson , 2003). In recent years, CTX-M type 
enzymes have been increasing in prevalence and have superseded TEM and SHV derivatives and 
Escherichia coli has become the most prevalent species among ESBL-producing 
Enterobacteriaceae (Bethel, 2011). These genes can be transmitted through binary fission or by 
horizontal transmission via plasmids. 
Materials and Methods 
Sampling Sites and Water Sample Collection 
Between August 2015 and March of 2016, water sampling was conducted at Flatwater Creek 
Water Reclamation Facility in Gainesville, Georgia. We collected 100 mL of both efferent and 
afferent samples from the plant on August 2015, September 2015, and March 2016. 100 ml of 
water samples were collected from approximately 50 cm below the water surface using sterile 
bottles. The collected water samples were stored on ice for 30 minutes for transport to the lab. 
Microbiological Analysis 
For each sample, 100 mL of water was filtered through sterile 0.45 μm membrane filters 
(Nalage, Rochester, NY, USA). The filters were removed and placed in 20 mL of enterobacteria 
enrichment (EE) Broth (Oxoid LTD, Hampshire, England) and incubated in a shaking incubator 
at 275 rpm for 24 h at 37 ºC. After incubation, a loop full of culture was streaked on an ESBL 
chromogenic Agar plates (Hardy Diagnostics, Santa Maria, CA) and incubated at 37°C for 24 
hours. The chromogenic plates contain a proprietary blend of antibiotics to select for multi-drug 
resistant strains and allow for easy identification of E.coli and Kelbsiella via the chromogens 
(pink and blue respectively). The colonies that grew on the chromogenic plates with different 
colors and morphologies were isolated, sub-cultured, and confirmed for multi-drug resistance. 
The antibiotic resistant enterobacterial species were identified by using API strips (Biomeriux) as 
per the manufacturer’s instruction. 
Antimicrobial Susceptibility Testing and ESBL Confirmation 
We selected these specific antibiotics to be representative of increasing levels of resistance 
within the beta-lactam structured drugs as well as non-beta-lactam drugs. The higher the 
generation, the more toxic the antibiotic. We used a first, second, third and fourth generation 
beta-lactams(Penicillin, Cefepime, Cefotaxime, Ceftazidime, Imipenem)  as well as we used 
three beta-lactams with clavulanic acid (Augmentin, Ceftazidime/Clavulanic Acid, 
Cefotaxime/Clavulanic Acid) a known beta-lactamase inhibitor. We also used four non-beta-
lactam antibiotics, (Chloramphenicol, Gentamycin, Tetracycline, Minocycline) that are common 
front line drugs. 
The disk diffusion method was used to test susceptibility of the isolates against 12 anti-microbial 
agents. The tested antibiotic concentrations: Cefotaxime-Clavulanic Acid 30/10µg, Cefotaxime 
30 µg, Ceftazidime-Clavulanic Acid 30/10µg, Cefepime 30µg, Chloramphenicol 30 µg, 
Imipenem 10µg, Minocycline 30µg, Tetracycline 30µg, and Gentamicin 120µg. Isolates showing 
resistance to three or more antibiotic classes were defined as multidrug resistant (MDR).  
Polymerase Chain Reaction (PCR) to Detect bla Genes 
We extracted genomic DNA from the bacterial isolates using a DNA extraction kit (Thermo 
Scientific). We performed PCR to detect blaTEM, blaCTX-M, blaSHV, and blaOXA genes 
using specific primers found in previously published work (Chen et al., 2010). We used a 1µg 
genomic DNA, 2.5 µL of forward primer, 2.5 µL of reverse primer, 19µL of sterile water, and 
one PCR bead (GE healthcare, UK), for a total reaction volume of 25µL 
Results 
Variety of ESBL-Producing Enterobacteriaceae Identified. Multidrug resistant ESBL producing 
enterobacteria were found in both the efferent and afferent samples obtained in all three trials. 26 
individual isolates were found to include Ent. coloacae (3), E. coli (5), Kl. Pneumoniae (9), Ent. 
intermedium (1), Ent. Aerogenes (4), Ent. Agglom Ind+ Sac+ (1), C. Freundii H2S-Ind (1), Ent. 
Agglom (1). Kluyvera Sp.(1).  
  
Antibiotic Resistance in Isolates 
We found some resistance to every antibiotic tested. The resistance followed the outcome we 
would have expected, and 99.96% to penicillin. 57% of the isolates were resistant to the third 
generation cephalosporin cefotaxime, while only 23% were resistant to the fourth generation 
cephalosporin cefepime. 50% of the isolates were resistant to the second generation tetracycline 
minocycline. 23.08% were resistant to the non-beta-lactam antibiotic chloramphenicol. 7.69% 












































































































bla Genes Present in Isolates  
The bla gene is a plasmid encoding gene which codes for the production of an enzyme called 
beta-lactamase. Beta-lactamases come in four variations classified as types A, B, C, and D. The 
bla gene has been identified in four forms the TEM, SHV, CTX, and OXA genes. We found that 
38.5% of all the isolates identified were positive for one of the four possible bla type gene. Of 
those, 50% of them were positive for two or more genes. 
Bla Gene Type Number of isolates containing the gene Percentage of Isolates 
SHV 4 15.4% 
CTX 5 19.2% 
OXA 3 11.5% 
TEM 5 19.2% 
Discussion 
In this study, 26 individual isolates of ESBL-producing Enterobacteriaceae were found in both 
efferent and afferent water samples from the Flat Creek Water Reclamation Facility in 
Gainesville, Georgia. This facility treats water that comes from industrial, healthcare, and 
residential waste. The ESBL Enterobacteriaceae that we found were all multi-drug resistant. 
They showed increasing resistance from the penicillin based antibiotics up through the third and 
fourth generation cephalosporins, as well as, resistance to the carbapenem. We also had 
resistance to the non-beta-lactam antibiotics showing that these isolates have developed more 
than one mechanism of resistance as beta-lactamase would have no effect on a drug without a 
beta-lactam ring in its structure. This suggests that these strains have been subjected to multiple 
selective pressures being in the constant presence of antibiotics, thus causing them to become 
resistant to higher order drugs. 
There were some limitations in this study: There were only three trials performed over the course 
of a year which may not be representative of the entire picture. One of the trials was done during 
February, which turned out to be a very cold day, and that is the reason we believe we got far 
fewer isolates out of that trial.  
We have given but a snapshot of the entire issue concerning ESBL in our community. In future 
studies we plan to look at the correlation between anthropological impact and the species and 
enumeration of ESBL producing bacteria. We also plan to look at possible seasonality to explain 
the reasoning for the winter data being significantly less than spring/summer.  
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